MAN1B1
Basic information
Region (hg38): 9:137086857-137109189
Links
Phenotypes
GenCC
Source:
- Rafiq syndrome (Strong), mode of inheritance: AR
- Rafiq syndrome (Strong), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- MAN1B1-congenital disorder of glycosylation (Supportive), mode of inheritance: AR
- Rafiq syndrome (Strong), mode of inheritance: AR
- MAN1B1-congenital disorder of glycosylation (Definitive), mode of inheritance: AR
- Rafiq syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Rafiq syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 20345473; 21763484; 21063731 |
ClinVar
This is a list of variants' phenotypes submitted to
- Rafiq_syndrome (396 variants)
- Inborn_genetic_diseases (204 variants)
- not_provided (101 variants)
- not_specified (41 variants)
- MAN1B1-related_disorder (22 variants)
- Intellectual_disability (4 variants)
- See_cases (2 variants)
- Intellectual_Disability,_Recessive (1 variants)
- MAN1B1-congenital_disorder_of_glycosylation (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAN1B1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016219.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 123 | 136 | ||||
| missense | 12 | 219 | 23 | 259 | ||
| nonsense | 10 | 15 | ||||
| start loss | 0 | |||||
| frameshift | 13 | 10 | 23 | |||
| splice donor/acceptor (+/-2bp) | 8 | |||||
| Total | 28 | 30 | 228 | 147 | 8 |
Highest pathogenic variant AF is 0.0001984277
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MAN1B1 | protein_coding | protein_coding | ENST00000371589 | 13 | 22257 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.18e-8 | 0.986 | 125693 | 0 | 55 | 125748 | 0.000219 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.726 | 448 | 407 | 1.10 | 0.0000258 | 4534 |
| Missense in Polyphen | 107 | 129.38 | 0.82705 | 1480 | ||
| Synonymous | -3.25 | 237 | 181 | 1.31 | 0.0000125 | 1393 |
| Loss of Function | 2.31 | 18 | 32.1 | 0.560 | 0.00000149 | 367 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000866 | 0.000865 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000218 | 0.000217 |
| Finnish | 0.0000466 | 0.0000462 |
| European (Non-Finnish) | 0.000232 | 0.000229 |
| Middle Eastern | 0.000218 | 0.000217 |
| South Asian | 0.000137 | 0.000131 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in glycoprotein quality control targeting of misfolded glycoproteins for degradation. It primarily trims a single alpha-1,2-linked mannose residue from Man(9)GlcNAc(2) to produce Man(8)GlcNAc(2), but at high enzyme concentrations, as found in the ER quality control compartment (ERQC), it further trims the carbohydrates to Man(5-6)GlcNAc(2). {ECO:0000269|PubMed:12090241, ECO:0000269|PubMed:18003979}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);N-Glycan biosynthesis - Homo sapiens (human);er associated degradation (erad) pathway;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;Post-translational protein modification;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;N-Glycan biosynthesis
(Consensus)
Intolerance Scores
- loftool
- 0.409
- rvis_EVS
- 0.19
- rvis_percentile_EVS
- 66.29
Haploinsufficiency Scores
- pHI
- 0.317
- hipred
- N
- hipred_score
- 0.206
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.194
Mouse Genome Informatics
- Gene name
- Man1b1
- Phenotype
Gene ontology
- Biological process
- protein glycosylation;N-glycan processing;oligosaccharide metabolic process;ubiquitin-dependent ERAD pathway;protein alpha-1,2-demannosylation;trimming of terminal mannose on B branch;trimming of terminal mannose on C branch;trimming of first mannose on A branch;trimming of second mannose on A branch;endoplasmic reticulum mannose trimming;mannose trimming involved in glycoprotein ERAD pathway
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;membrane;integral component of membrane;endoplasmic reticulum quality control compartment;extracellular vesicle
- Molecular function
- mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;calcium ion binding